Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can acupuncture ease breast cancer pain? new trial investigates

NCT ID NCT02754752

Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial tests whether electroacupuncture can reduce chronic pain in women who have completed treatment for stage I-III breast cancer. 111 participants will receive either real acupuncture, sham acupuncture, or no treatment. The goal is to see if this gentle needle therapy can lower pain scores and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
electroacupuncture
What this could lead to
If it works, this could offer a drug-free option for managing long-term pain after breast cancer surgery.
What could go wrong
This is a mid-stage trial with only 111 participants, so results may not apply to everyone. The sham acupuncture group also limits how much benefit is truly from the needles.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

111 people

The number who actually took part.

Started

Sep 2016

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be adult women \>/= 18 years of age. * Be able to read, write, and speak English * Able to give informed consent * Have a history of stage I, II, or III breast cancer * Have a documented visit with an oncologist during the previous 12-months * Have no current evidence of disease * Have persistent pain (unrelated to aromatase inhibitors or chemotherapy-induced peripheral neuropathy) for at least 3 months following treatment for breast cancer * Have pain severity (arithmetic mean of four pain severity items) \>= 2 on Brief Pain Inventory (BPI) * Have worst pain \>= to 4 (0-10 numeric rating scale \[NRS\]) in the preceding week * Be willing and able to adhere to all study-related procedures * Have completed all cancer treatment (including surgery, chemotherapy and/or radiation) at least 4 months prior to enrollment * Have documented lab work with absolute neutrophil count (ANC) \>= 1.0 K/uL and platelets \>= 50 K/uL in the past 12 months * If applicable, maintain self-management of lymphedema symptoms being performed at home at time of study entry Exclusion Criteria: * Metastatic breast cancer (stage IV) * Known bleeding disorder per patient reported history * Cardiac pacemaker or other implanted electronic devices * New or planned new lymphedema treatment during the study period * Currently receiving or ever received acupuncture for present pain condition * Received acupuncture with electrical stimulation for any condition * Received acupuncture for any condition in the past year

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stage I breast cancer ajcc V7 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stage I breast cancer ajcc V7 Stage IA breast cancer ajcc V7 Stage IB breast cancer ajcc V7 Stage II breast cancer ajcc V6 and V7 Stage IIA breast cancer ajcc V6 and V7 Stage IIB breast cancer ajcc V6 and V7 Stage III breast cancer ajcc V7 Stage IIIA breast cancer ajcc V7 Stage IIIB breast cancer ajcc V7 Stage IIIC breast cancer ajcc V7

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.